197 related articles for article (PubMed ID: 31102405)
41. Expression of Tim-1 in primary CNS lymphoma.
Kishimoto W; Nishikori M; Arima H; Miyoshi H; Sasaki Y; Kitawaki T; Shirakawa K; Kato T; Imaizumi Y; Ishikawa T; Ohno H; Haga H; Ohshima K; Takaori-Kondo A
Cancer Med; 2016 Nov; 5(11):3235-3245. PubMed ID: 27709813
[TBL] [Abstract][Full Text] [Related]
42. Testicular Relapse of Primary Diffuse Large B-cell Lymphoma of the Central Nervous System - a Rare Occurrence.
Ollila TA; Kishkovich TP; Olszewski AJ; Patel NR; Jackson C; Roussel B; Niroula R; Treaba DO
R I Med J (2013); 2023 Mar; 106(2):8-12. PubMed ID: 36848533
[TBL] [Abstract][Full Text] [Related]
43. Primary central nervous system diffuse large B-cell lymphoma shows an activated B-cell-like phenotype with co-expression of C-MYC, BCL-2, and BCL-6.
Li X; Huang Y; Bi C; Yuan J; He H; Zhang H; Yu Q; Fu K; Li D
Pathol Res Pract; 2017 Jun; 213(6):659-665. PubMed ID: 28552541
[TBL] [Abstract][Full Text] [Related]
44. Identification of novel recurrent ETV6-IgH fusions in primary central nervous system lymphoma.
Bruno A; Labreche K; Daniau M; Boisselier B; Gauchotte G; Royer-Perron L; Rahimian A; Lemoine F; de la Grange P; Guégan J; Bielle F; Polivka M; Adam C; Meyronet D; Figarella-Branger D; Villa C; Chrétien F; Eimer S; Davi F; Rousseau A; Houillier C; Soussain C; Mokhtari K; Hoang-Xuan K; Alentorn A
Neuro Oncol; 2018 Jul; 20(8):1092-1100. PubMed ID: 29432597
[TBL] [Abstract][Full Text] [Related]
45. Primary central nervous system lymphoma: immunohistochemical profile and prognostic significance.
Raoux D; Duband S; Forest F; Trombert B; Chambonnière ML; Dumollard JM; Khaddage A; Gentil-Perret A; Péoc'h M
Neuropathology; 2010 Jun; 30(3):232-40. PubMed ID: 19925562
[TBL] [Abstract][Full Text] [Related]
46. Microarray Gene-expression Profiling Analysis Comparing PCNSL and Non-CNS Diffuse Large B-Cell Lymphoma.
Lim DH; Kim WS; Kim SJ; Yoo HY; Ko YH
Anticancer Res; 2015 Jun; 35(6):3333-40. PubMed ID: 26026093
[TBL] [Abstract][Full Text] [Related]
47. Atypical presentation of primary central nervous system non-Hodgkin lymphoma in immunocompetent young adults.
Cheatle JT; Aizenberg MR; Weinberg JS; Surdell DL
World Neurosurg; 2013; 79(3-4):593.e9-13. PubMed ID: 22885166
[TBL] [Abstract][Full Text] [Related]
48. Analysis of immunoglobulin H gene rearrangement by polymerase chain reaction in primary central nervous system lymphoma.
Kros JM; Bagdi EK; Zheng P; Hop WC; Driesse MJ; Krenacs L; Dinjens WN
J Neurosurg; 2002 Dec; 97(6):1390-6. PubMed ID: 12507138
[TBL] [Abstract][Full Text] [Related]
49. Primary central nervous system lymphoma.
Gerstner ER; Batchelor TT
Arch Neurol; 2010 Mar; 67(3):291-7. PubMed ID: 20212226
[TBL] [Abstract][Full Text] [Related]
50. Mutations of CARD11 but not TNFAIP3 may activate the NF-kappaB pathway in primary CNS lymphoma.
Montesinos-Rongen M; Schmitz R; Brunn A; Gesk S; Richter J; Hong K; Wiestler OD; Siebert R; Küppers R; Deckert M
Acta Neuropathol; 2010 Oct; 120(4):529-35. PubMed ID: 20544211
[TBL] [Abstract][Full Text] [Related]
51. Promoter methylation attenuates SHP1 expression and function in patients with primary central nervous system lymphoma.
Liu J; Wang Y; Sun X; Ji N; Sun S; Wang Y; Liu F; Cui Q; Wang C; Liu Y
Oncol Rep; 2017 Feb; 37(2):887-894. PubMed ID: 27959415
[TBL] [Abstract][Full Text] [Related]
52. Primary central nervous system lymphoma: Novel precision therapies.
Mondello P; Mian M; Bertoni F
Crit Rev Oncol Hematol; 2019 Sep; 141():139-145. PubMed ID: 31295667
[TBL] [Abstract][Full Text] [Related]
53. The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells.
Larocca LM; Capello D; Rinelli A; Nori S; Antinori A; Gloghini A; Cingolani A; Migliazza A; Saglio G; Cammilleri-Broet S; Raphael M; Carbone A; Gaidano G
Blood; 1998 Aug; 92(3):1011-9. PubMed ID: 9680371
[TBL] [Abstract][Full Text] [Related]
54. Absence of Lymphatic Vessels in PCNSL May Contribute to Confinement of Tumor Cells to the Central Nervous System.
Deckert M; Brunn A; Montesinos-Rongen M; Siebert R
J Neuropathol Exp Neurol; 2016 Jun; 75(6):499-502. PubMed ID: 27142645
[TBL] [Abstract][Full Text] [Related]
55. Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrence.
Magnes T; Wagner S; Thorner AR; Neureiter D; Klieser E; Rinnerthaler G; Weiss L; Huemer F; Zaborsky N; Steiner M; Weis S; Greil R; Egle A; Melchardt T
ESMO Open; 2021 Feb; 6(1):100012. PubMed ID: 33399078
[TBL] [Abstract][Full Text] [Related]
56. Primary Central Nervous System Lymphomas: A Diagnostic Overview of Key Histomorphologic, Immunophenotypic, and Genetic Features.
Lauw MIS; Lucas CG; Ohgami RS; Wen KW
Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33322508
[TBL] [Abstract][Full Text] [Related]
57. PD1 and PDL1 expression in primary central nervous system diffuse large B-cell lymphoma are frequent and expression of PD1 predicts poor survival.
Four M; Cacheux V; Tempier A; Platero D; Fabbro M; Marin G; Leventoux N; Rigau V; Costes-Martineau V; Szablewski V
Hematol Oncol; 2017 Dec; 35(4):487-496. PubMed ID: 27966264
[TBL] [Abstract][Full Text] [Related]
58. Primary Central Nervous System Lymphoma (PCNSL) - A Rare and Unusual Presentation of Rapidly Progressive Major Cognitive Dysfunction.
Nand L; Gupta D; Sharma S; Kumar S
J Assoc Physicians India; 2021 Feb; 69(2):68-70. PubMed ID: 33527818
[TBL] [Abstract][Full Text] [Related]
59. Molecular and clinical diversity in primary central nervous system lymphoma.
Hernández-Verdin I; Kirasic E; Wienand K; Mokhtari K; Eimer S; Loiseau H; Rousseau A; Paillassa J; Ahle G; Lerintiu F; Uro-Coste E; Oberic L; Figarella-Branger D; Chinot O; Gauchotte G; Taillandier L; Marolleau JP; Polivka M; Adam C; Ursu R; Schmitt A; Barillot N; Nichelli L; Lozano-Sánchez F; Ibañez-Juliá MJ; Peyre M; Mathon B; Abada Y; Charlotte F; Davi F; Stewart C; de Reyniès A; Choquet S; Soussain C; Houillier C; Chapuy B; Hoang-Xuan K; Alentorn A
Ann Oncol; 2023 Feb; 34(2):186-199. PubMed ID: 36402300
[TBL] [Abstract][Full Text] [Related]
60. [Prognostic Analysis of Primary Central Nervous System Lymphoma Patients with Diffuse Large B-Cell Immunophenotype].
Fan XH; Xu YQ; Zhu F; Xu KL; Li ZY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):484-487. PubMed ID: 32319383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
